Cancer chemotherapy and cognitive function in rodent models: Memory impairment induced by cyclophosphamide in mice [1]

Clinical Cancer Research

Volumn 12, Issue 16, 2006, Pages 5000-

  Reiriz, André B ^a   Reolon, Gustavo K ^b   Preissler, Thales ^b   Rosado, Joemerson O ^b   Henriques, João Antônio P ^b   Roesler, Rafael ^b   Schwartsmann, Gilberto ^b  

^a UNIVERSITY OF CAXIAS DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANXIETY; CANCER CHEMOTHERAPY; CANCER RESEARCH; COGNITIVE DEFECT; DOSE RESPONSE; EMOTIONALITY; HIPPOCAMPUS; HUMAN; LETTER; LOCOMOTION; MEMORY DISORDER; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; RANK SUM TEST;

ANIMALS; COGNITION DISORDERS; CYCLOPHOSPHAMIDE; FLUOROURACIL; HIPPOCAMPUS; MALE; MEMORY; MEMORY DISORDERS; MICE;

EID: 33748369693     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0138     Document Type: Letter

References (4)

1. Lee GD, Longo DL, Wang Y, et al. Transient improvement in cognitive function and synaptic plasticity in rats following cancer chemotherapy. Clin Cancer Res 2006;12:198-205.
2. Minisini A, Atalay G, Bottomley A, Puglisi F, Piccart M, Biganzoli L. What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncol 2004;5:273-82.
3. Tannock IF, Ahles TA, Ganz PA, Van Dam FS. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 2004;22:2233-9.
4. Roesler R, Walz R, Quevedo J, et al. Normal inhibitory avoidance learning and anxiety, but increased locomotor activity in mice devoid of PrPc. Brain Res Mol Brain Res 1999;71:349-53.